Reliability of the sentinel node procedure in melanoma patients: Analysis of failures after long-term follow-up

Annals of Surgical Oncology

Volumn 7, Issue 6, 2000, Pages 461-468

  Statius Muller, Markwin G ^a   Borgstein, Paul J ^a   Pijpers, Rik ^a   Van Leeuwen, Paul A M ^a   Van Diest, Paul J ^a   Gupta, Anurag ^a   Meijer, Sybren ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

False negative; Follow up; Locoregional lymph basin recurrence; Melanoma; Sentinel node procedure; Success rate

Indexed keywords

NANOCOLL; NANOCOLL TC 99M;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHADENECTOMY; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MELANOMA; SURGICAL TECHNIQUE; TREATMENT FAILURE; ULCER;

EID: 0007747103     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0461-7     Document Type: Article

References (34)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
2. Reintgen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal metastases. Ann Surg 1994;220:759-67.
3. Thompson JF, McCarthy WH, Bosch CM, et al. Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995;5:255-60.
4. Cascinelli N, Morabito A, Santinami M, MacKie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 1998;351:793-6.
5. Kirkwood JM, Strawderman MH, Ernstoff MS, Smith TJ, Borden EC, Blum RH. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996;14:7-17.
6. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol 1999;17:976-83.
7. The 1st International Congress on the Sentinel Node in Diagnosis and Treatment of Cancer. Amsterdam, The Netherlands, April 7-10, 1999. Proceedings and abstracts. Eur J Nucl Med 1999; 26(Suppl):S1-S103.
8. Gershenwald JE, Colome MI, Lee JE, et al. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma. J Clin Oncol 1998;16:2253-60.
9. Van der Veen H, Hoekstra OS, Paul MA, Cuesta MA, Meijer S. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphadenectomy. Br J Surg 1994;81:1769-70.
10. Van Diest PJ, Peterse HL, Borgstein PJ, Hoekstra O, Meijer CJ. Pathological investigation of sentinel lymph nodes. Eur J Nucl Med 1999;26(Suppl):S43-S49.
11. Karakousis CP, Balch CM, Urist MM, Ross MM, Smith TJ, Bartolucci AA. Local recurrence in malignant melanoma: long-term results of the multi-institutional randomized surgical trial. Ann Surg Oncol 1996;3:446-52.
12. Stehlin JSJ, Smith JLJ, Jing BS, Sherrin D. Melanomas of the extremities complicated by in-transit metastases. Surg Gynecol Obstet 1966;122:3-14.
13. Borgstein PJ, Meijer S, van Diest PJ. Are locoregional cutaneous metastases in melanoma predictable? Ann Surg Oncol 1999;6:315-21.
14. Statius Muller MG, van Leeuwen PA, Borgstein PJ, Pijpers R, Meijer S. The sentinel node procedure in cutaneous melanoma: an overview of 6 years' experience. Eur J Nucl Med 1999;26(Suppl): S20-S25.
15. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radiolympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217-24.
16. Glass LF, Messina JL, Cruse W, et al. The use of intraoperative radiolymphoscintigraphy for sentinel node biopsy in patients with malignant melanoma. Dermatol Surg 1996;22:715-20.
17. Kapteijn BA, Nieweg OE, Liem I, et al. Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol 1997;4:156-60.
18. Leong SP, Steinmetz, I, Habib FA, et al. Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg 1997;132:666-72.
19. Pijpers R, Borgstein PJ, Meijer S, Hoekstra OS, van Hattum LH, Teule GJ. Sentinel node biopsy in melanoma patients: dynamic lymphoscintigraphy followed by intraoperative gamma probe and vital dye guidance. World J Surg 1997;21:788-92.
20. Bennett LR, Lago G. Cutaneous lymphoscintigraphy in malignant melanoma. Semin Nucl Med 1983;13:61-9.
21. Pijpers R, Collet GJ, Meijer S, Hoekstra OS. The impact of dynamic lymphoscintigraphy and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 1995;22:1238-41.
22. Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH. Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 1993;34:1435-40.
23. Balch CM, Urist MM, Karakousis CP, et al. Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg 1993;218:262-7.
24. Pijpers R, Borgstein PJ, Meijer S, et al., Transport and retention of colloidal tracers in regional lymphoscintigraphy in melanoma: influence on lymphatic mapping and sentinel node biopsy. Melanoma Res 1998;8:413-8.
25. Alazraki N. Lymphoscintigraphy and the intraoperative gamma probe. J Nucl Med 1995;36:1780-3.
26. Kelley MC, Ollila DW, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for melanoma. Semin Surg Oncol 1998; 14:283-90.
27. Blaheta HJ, Schittek B, Breuninger H, et al. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin. Am J Surg Pathol 1999;23:822-8.
28. Van der Velde-Zimmermann D, Roijers JF, Bouwens-Rombouts A, et al. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Am J Pathol 1996;149:759-64.
29. Borgstein P, Meijer S. Historical perspective of lymphatic tumour spread and the emergence of the sentinel node concept. Eur J Surg Oncol 1998;24:85-9.
30. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-83.
31. Foster RS, Jr. The biologic and clinical significance of lymphatic metastases in breast cancer. Surg Oncol Clin North America 1996; 5:79-104.
32. Roses DF, Harris MN, Rigel D, Carrey Z, Friedman R, Kopf AW. Local and in-transit metastases following definitive excision for primary cutaneous malignant melanoma. Ann Surg 1983;198: 65-9.
33. Ames FC, Sugarbaker EV, Ballantyne AJ. Analysis of survival and disease control in stage I melanoma of the head and neck. Am J Surg 1976;132:484-91.
34. McNeer G, Cantin J. Local failure in the treatment of melanoma. The Janeway lecture, 1966. Am J Roentgenol Radium Ther Nucl Med 1967;99:791-808.